.svg){kind=small}
Jul-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Chronic Health has demonstrated consistent performance in the Arizona market, particularly within the Tincture & Sublingual and Topical categories. In both categories, the brand has maintained a steady rank of 2nd place from April to July 2025. This stability in ranking suggests a strong foothold in these segments, although there is a noticeable decline in sales figures over the same period. For instance, in the Tincture & Sublingual category, sales decreased from $42,355 in April to $25,228 in July. This trend could indicate increasing competition or shifting consumer preferences, which might require strategic adjustments to maintain market share.
While Chronic Health's performance in Arizona remains robust across these categories, it's important to note that the brand is not listed in the top 30 for other cannabis categories or states, suggesting areas for potential growth and expansion. The absence from rankings in additional categories could either be a strategic focus on their current strengths or a missed opportunity in diversifying their product offerings. This absence highlights the competitive nature of the cannabis market and the need for brands to continually innovate and adapt to maintain and improve their standings across different regions and product lines.
Competitive Landscape
In the competitive landscape of the topical cannabis market in Arizona, Chronic Health has maintained a consistent rank of 2nd place from April to July 2025. Despite this stability in ranking, its sales have experienced a downward trend, which could be a point of concern for the brand. Meanwhile, iLava started as the top brand in April and May but saw a decline to 4th place by July, indicating a significant drop in consumer preference or market dynamics. On the other hand, Drip Oils + Extracts showed a remarkable rise, moving from 3rd place in April to the top spot by June and July, suggesting a strong upward momentum in sales and market share. Tru Infusion remained stable in the 3rd and 4th positions, indicating consistent performance. These shifts highlight the competitive pressures Chronic Health faces, particularly from brands like Drip Oils + Extracts, which are gaining traction and could potentially impact Chronic Health's market share if current trends continue.
Notable Products
In July 2025, the top-performing product for Chronic Health was the Indica THC Glycerin Tincture (100mg THC, 1oz) in the Tincture & Sublingual category, maintaining its number 1 rank from April and June, despite a slight decrease in sales to 522 units. The CBD/THC 1:1 Sleep Well Tincture (100mg CBD, 100mg THC, 1oz) secured the second position, showing consistent performance since May. The CBD/THC 1:1 Glycerin Tincture (100mg CBD, 100mg THC, 1oz) retained its third-place ranking from June, indicating stable demand. The CBD/THC 1:1 Pain Relief Ointment (175mg CBD, 175mg THC, 2oz) and the CBD/THC 1:1 Pain Relief Ointment (45mg CBD, 45mg THC) maintained their fourth and fifth ranks respectively, with the smaller ointment showing a notable sales increase from the previous month. Overall, the product rankings for Chronic Health remained stable from June to July, with minor fluctuations in sales figures.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
